Cargando…

SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture

Context: Primary aldosteronism (PA) is known to increase vertebral fracture (VF), although the detailed mechanism remains to be elucidated. PA consists of two subtypes: the unilateral and bilateral subtype. Patients with unilateral PA, who usually have a higher plasma aldosterone concentration than...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Ryuichi, Yokomoto-Umakoshi, Maki, Umakoshi, Hironobu, Matsuda, Yayoi, Hiromi, Nagata, Fukumoto, Tazuru, Ogata, Masatoshi, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209558/
http://dx.doi.org/10.1210/jendso/bvaa046.804
_version_ 1783531106409119744
author Sakamoto, Ryuichi
Yokomoto-Umakoshi, Maki
Umakoshi, Hironobu
Matsuda, Yayoi
Hiromi, Nagata
Fukumoto, Tazuru
Ogata, Masatoshi
Ogawa, Yoshihiro
author_facet Sakamoto, Ryuichi
Yokomoto-Umakoshi, Maki
Umakoshi, Hironobu
Matsuda, Yayoi
Hiromi, Nagata
Fukumoto, Tazuru
Ogata, Masatoshi
Ogawa, Yoshihiro
author_sort Sakamoto, Ryuichi
collection PubMed
description Context: Primary aldosteronism (PA) is known to increase vertebral fracture (VF), although the detailed mechanism remains to be elucidated. PA consists of two subtypes: the unilateral and bilateral subtype. Patients with unilateral PA, who usually have a higher plasma aldosterone concentration than those with bilateral PA, exhibit a more severe clinical phenotype. We hypothesized that PA subtype affects the prevalence of VF. Objective: To evaluate whether unilateral PA is associated with the prevalence of VF. Design: Cross-sectional study in a single referral center. Patients: We identified 210 hypertensive patients whose clinical data were available for case-detection results. One hundred and fifty-two patients were diagnosed with PA using captopril challenge tests. Measurements: The prevalence of VF according to PA subtype. Results: We included 113 patients with PA who were subtype classified according to adrenal vein sampling, of whom 37 patients had unilateral PA and 76 patients had bilateral PA, whereas 58 patients had non-PA. We excluded 39 patients with PA who were not subtype classified. Patients with PA had a higher prevalence of VF (28% [32/113]) than those with non-PA (12% [7/58]; p = 0.020). Moreover, unilateral PA had a higher prevalence of VF (46% [17/37]) than bilateral PA (20% [15/76]; p = 0.021). There was no significant difference between bilateral PA and non-PA. Unilateral PA was an independent risk factor for VF after adjusting for age and sex (odds ratio, 3.16; 95% confidence interval, 1.12-8.92; p = 0.017). Among patients with unilateral PA, serum cortisol concentrations after 1 mg dexamethasone suppression test were higher in those with VF (1.32 ± 0.67 g/dl) than those without (0.96 ± 0.33 g/dl; p = 0.048). Conclusions: Unilateral PA is an independent risk factor for VF, which is associated with autonomous cortisol secretion. Thus, careful management is required to prevent the development of VF in patients with unilateral PA.
format Online
Article
Text
id pubmed-7209558
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72095582020-05-13 SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture Sakamoto, Ryuichi Yokomoto-Umakoshi, Maki Umakoshi, Hironobu Matsuda, Yayoi Hiromi, Nagata Fukumoto, Tazuru Ogata, Masatoshi Ogawa, Yoshihiro J Endocr Soc Bone and Mineral Metabolism Context: Primary aldosteronism (PA) is known to increase vertebral fracture (VF), although the detailed mechanism remains to be elucidated. PA consists of two subtypes: the unilateral and bilateral subtype. Patients with unilateral PA, who usually have a higher plasma aldosterone concentration than those with bilateral PA, exhibit a more severe clinical phenotype. We hypothesized that PA subtype affects the prevalence of VF. Objective: To evaluate whether unilateral PA is associated with the prevalence of VF. Design: Cross-sectional study in a single referral center. Patients: We identified 210 hypertensive patients whose clinical data were available for case-detection results. One hundred and fifty-two patients were diagnosed with PA using captopril challenge tests. Measurements: The prevalence of VF according to PA subtype. Results: We included 113 patients with PA who were subtype classified according to adrenal vein sampling, of whom 37 patients had unilateral PA and 76 patients had bilateral PA, whereas 58 patients had non-PA. We excluded 39 patients with PA who were not subtype classified. Patients with PA had a higher prevalence of VF (28% [32/113]) than those with non-PA (12% [7/58]; p = 0.020). Moreover, unilateral PA had a higher prevalence of VF (46% [17/37]) than bilateral PA (20% [15/76]; p = 0.021). There was no significant difference between bilateral PA and non-PA. Unilateral PA was an independent risk factor for VF after adjusting for age and sex (odds ratio, 3.16; 95% confidence interval, 1.12-8.92; p = 0.017). Among patients with unilateral PA, serum cortisol concentrations after 1 mg dexamethasone suppression test were higher in those with VF (1.32 ± 0.67 g/dl) than those without (0.96 ± 0.33 g/dl; p = 0.048). Conclusions: Unilateral PA is an independent risk factor for VF, which is associated with autonomous cortisol secretion. Thus, careful management is required to prevent the development of VF in patients with unilateral PA. Oxford University Press 2020-05-08 /pmc/articles/PMC7209558/ http://dx.doi.org/10.1210/jendso/bvaa046.804 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Bone and Mineral Metabolism
Sakamoto, Ryuichi
Yokomoto-Umakoshi, Maki
Umakoshi, Hironobu
Matsuda, Yayoi
Hiromi, Nagata
Fukumoto, Tazuru
Ogata, Masatoshi
Ogawa, Yoshihiro
SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title_full SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title_fullStr SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title_full_unstemmed SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title_short SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
title_sort sun-378 unilateral primary aldosteronism as an independent risk factor for vertebral fracture
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209558/
http://dx.doi.org/10.1210/jendso/bvaa046.804
work_keys_str_mv AT sakamotoryuichi sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT yokomotoumakoshimaki sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT umakoshihironobu sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT matsudayayoi sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT hirominagata sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT fukumototazuru sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT ogatamasatoshi sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture
AT ogawayoshihiro sun378unilateralprimaryaldosteronismasanindependentriskfactorforvertebralfracture